The signed advance purchase agreement (APA) will make up to 414 million doses of the Clover vaccine candidate available to the COVAX Facility, pending WHO Emergency Use Listing (EUL) Supply will be available to self-financing participants of the COVAX Facility as well as lower-income economies eligible to be supported by the Gavi COVAX Advance market […]
Gavi, UNICEF and partners collaborate on nationwide introduction, which will see all children from the age of two months protected from pneumonia by 2022 The country has received 1.6 million doses of the vaccine procured through the Gavi Pneumococcal Advanced Market Commitment mechanism Anuradha Gupta: “Congratulations to the Government of Indonesia on this milestone, which will save […]
Gavi Board makes key strategic decisions to support Gavi’s 5.0 strategy of leaving no child behind through immunisation; doubles down on ambitious targets for COVAX New market-shaping strategy, alliances with civil society among measures aimed at reducing the number of children receiving no doses of vaccine, by 25% globally – by 2025 US$ 775 million […]
Geneva, 24 June 2021 – Global health leaders Gavi, the Vaccine Alliance and the Global Fund to Fight AIDS, Tuberculosis and Malaria have joined forces with the International Federation of Accountants (IFAC) to contribute to, and support, the implementation of robust accounting practices in the public health sector and to improve overall financial management of donor funds by implementing countries.Through […]
23 June 2021 – by Aurélia Nguyen, Managing Director, Office of the COVAX Facility COVAX’s latest supply forecast is now published. According to this latest assessment, the vaccines pillar of the ACT-Accelerator will have 1.9 billion doses available for supply by the end of 2021 and, thanks to a number of recently signed advance purchase agreements, now […]
Geneva, 18 June 2021 – The Executive Board recognized Unitaid’s leadership and agility in responding to COVID-19 and discussed new challenges and opportunities facing the organization during its 38th meeting, held virtually from 16th to 18th June. Unitaid’s board reaffirmed its commitment to its core work and explored lessons learned from the pandemic response and ways its innovative model and […]
Agreement brokered by Unitaid and CHAI under the COVID-19 Oxygen Emergency Taskforce sees two of the world’s largest medical oxygen suppliers each collaborate with these ACT-Accelerator partners on increased access in low- and middle-income countries (LMICs) Two memoranda of understanding, one with Air Liquide and another with Linde, pave the way for increased oxygen supply […]
COVAX welcomes dose sharing commitments for 870 million additional doses to support equitable access to vaccines in 2021 and 2022, with the aim to deliver at least half by the end of 2021 The G7 has committed one billion doses since the February 2021 virtual G7 Early Leaders’ Summit, including pledges made at the G20 […]
Geneva, 10 June 2021 – Unitaid has been informed by the Government of the United Kingdom that our funding from the UK has been cut from an expected £77 million in 2021 to just £6 million. This includes a deferred contribution of £33 million from 2020. While recognising that the pandemic has placed governments in an unexpected […]
US Government scheme, announced today, will see 500 million doses of the Pfizer-BioNTech vaccine distributed through the COVAX Facility Deliveries will begin in August, with 200 million to be shipped in 2021 and a further 300 million by June 2022 Geneva, 10 June 2021 – Gavi, the Vaccine Alliance, today welcomes the decision by the United States […]
MEDIA RELEASE 2 June 2021 The Australian Global Health Alliance and Pacific Friends of Global Health welcome the news that the Australian Government has pledged an additional $50 million to COVAX, the global mechanism to ensure access to safe and equitable access to COVID-19 vaccines for 92 of the world’s poorest countries. Today’s commitment […]
The Gavi COVAX AMC Summit “One World Protected” virtual event, hosted today by the Government of Japan and Gavi, the Vaccine Alliance, raised US$ 2.4 billion from nearly 40 donor governments, the private sector and foundations, exceeding the funding target and bringing the total pledged to the COVAX AMC to US$ 9.6 billion to date […]
Responding to an urgent need for doses around the world, the Government of New Zealand has pledged to transfer 1.6 million doses allocated through COVAX to lower-income economies. These doses, entirely funded by New Zealand, will go to a number of low- and middle-income countries, with the first 211,200 allocated to six economies in the […]
